CELLULAR-SENSITIVITY AND LOW DOSE-RATE RECOVERY IN FANCONI-ANEMIA FIBROBLASTS

被引:12
作者
BURNET, NG
WURM, R
TAIT, DM
PEACOCK, JH
机构
[1] INST CANC RES,RADIOTHERAPY RES UNIT,SUTTON SM2 7NG,SURREY,ENGLAND
[2] ROYAL MARSDEN HOSP,SUTTON SM2 7NG,SURREY,ENGLAND
关键词
D O I
10.1259/0007-1285-67-798-579
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Fanconi anaemia (FA) is a rare inherited condition characterized by developmental abnormalities and progressive bone marrow failure, which requires bone marrow transplantation for successful treatment. This involves the use of alkylating agents and total body or thoraco-abdominal irradiation. Both chemical clastogens and irradiation cause increased chromosome damage in FA cells compared with controls. In some studies FA fibroblasts have been found to be more radiosensitive than normal. From these data it has been inferred that patients with FA might be more sensitive than normal to radiotherapy. However, increased radiosensitivity of FA fibroblasts has not been a uniform finding. The radiosensitivity of fibroblasts from two FA patients was studied at high and low dose-rate (LDR), and their sensitivity compared with normal strains. Both FA strains fell at the sensitive end of the range, but both demonstrated marked dose-rate sparing, with D-0.01 recovery factors of 1.23 and 1.27, similar to the normal strains. These recovery factors are inconsistent with the suggestion that FA patients are recovery deficient. The data indicate that at least some FA strains are capable of LDR recovery, and imply that these patients would probably have a clinical benefit from fractionated or low dose-rate total body irradiation.
引用
收藏
页码:579 / 583
页数:5
相关论文
共 20 条
[1]  
Arlett C. F., 1979, Radiation Research. Proceedings of the Sixth International Congress of Radiation Research, P596
[2]  
ARLETT CF, 1980, CANCER RES, V40, P926
[3]   SUSCEPTIBILITY OF FANCONIS ANEMIA FIBROBLASTS TO CHROMOSOME-DAMAGE BY CARCINOGENS [J].
AUERBACH, AD ;
WOLMAN, SR .
NATURE, 1976, 261 (5560) :494-496
[4]   PREDICTION OF NORMAL-TISSUE TOLERANCE TO RADIOTHERAPY FROM INVITRO CELLULAR RADIATION SENSITIVITY [J].
BURNET, NG ;
NYMAN, J ;
TURESSON, I ;
WURM, R ;
YARNOLD, JR ;
PEACOCK, JH .
LANCET, 1992, 339 (8809) :1570-1571
[5]  
BURNET NG, IN PRESS RADIOTHER O
[6]   REEVALUATION OF INVITRO RADIOSENSITIVITY OF HUMAN-FIBROBLASTS OF DIFFERENT GENETIC ORIGINS [J].
DESCHAVANNE, PJ ;
DEBIEU, D ;
FERTIL, B ;
MALAISE, EP .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1986, 50 (02) :279-293
[7]  
DIBARTOLOMEO P, 1992, BONE MARROW TRANSPL, V10, P53
[8]   IDENTIFICATION OF A HELA MESSENGER-RNA FRACTION WHICH CAN CORRECT THE DNA-REPAIR DEFECT IN FANCONI ANEMIA FIBROBLASTS [J].
DIGWEED, M ;
SPERLING, K .
MUTATION RESEARCH, 1989, 218 (03) :171-177
[9]   RESPONSE OF HUMAN-FIBROBLASTS TO LOW-DOSE RATE GAMMA-IRRADIATION [J].
DRITSCHILO, A ;
BRENNAN, T ;
WEICHSELBAUM, RR ;
MOSSMAN, KL .
RADIATION RESEARCH, 1984, 100 (02) :387-395
[10]  
DUCKWORTHRYSIECKI G, 1985, CANCER RES, V45, P416